JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258713

Human TAP2 knockout A549 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TAP2 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon4 and 1 bp insertion in exon4 and 2 bp insertion in exon4.

View Alternative Names

ABC transporter, MHC 2, ABC18, ABCB3, APT-2, ATP binding cassette, sub family B (MDR/TAP), member 3, ATP-binding cassette sub-family B member 3, Antigen peptide transporter 2, D6S217E, Peptide supply factor 2, Peptide transporter PSF2, Peptide transporter TAP2, Peptide transporter involved in antigen processing 2, RING 11, Really interesting new gene 11 protein, TAP2_HUMAN, Transporter 2 ATP binding cassette sub family B, Transporter 2, ABC (ATP binding cassette, Transporter 2, ATP binding cassette, sub family B (MDR/TAP)

3 Images
Sanger Sequencing - Human TAP2 knockout A549 cell lysate (AB258713)
  • Sanger seq

Unknown

Sanger Sequencing - Human TAP2 knockout A549 cell lysate (AB258713)

Allele-2 : 1 bp insertion in exon4

Sanger Sequencing - Human TAP2 knockout A549 cell lysate (AB258713)
  • Sanger seq

Unknown

Sanger Sequencing - Human TAP2 knockout A549 cell lysate (AB258713)

Allele-1 : 11 bp deletion in exon4

Sanger Sequencing - Human TAP2 knockout A549 cell lysate (AB258713)
  • Sanger seq

Unknown

Sanger Sequencing - Human TAP2 knockout A549 cell lysate (AB258713)

Allele-3 : 2 bp insertion in exon4

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon4 and 1 bp insertion in exon4 and 2 bp insertion in exon4.

Disease

Carcinoma

style
left-column

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

style
left-column

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258713-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TAP2 knockout A549 cell lysate", "number":"AB258713-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A549 cell lysate", "number":"AB258713-CMP01", "productcode":"" } ] } } }
style
left-column

Properties and storage information

Gene name
TAP2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TAP2 also known as Transporter 2 ATP Binding Cassette Subfamily B Member has a mass of approximately 76 kDa. It functions as a part of the peptide-loading complex where it plays a mechanical role in transporting antigen peptides into the endoplasmic reticulum. TAP2 is expressed primarily in antigen-presenting cells such as B cells dendritic cells and macrophages. It is an integral membrane protein located in the membrane of the endoplasmic reticulum.
Biological function summary

The TAP2 protein operates as an important component of the immune system by facilitating the processing and presentation of antigens. It partners with TAP1 and forms a heterodimer complex essential for the transportation of peptides that are 8-16 amino acids long. This action is fundamental for the proper presentation of antigens on major histocompatibility complex (MHC) class I molecules which are pivotal in the recognition of infected or abnormal cells by cytotoxic T lymphocytes.

Pathways

The TAP2 protein plays a significant role in the antigen processing and presentation pathways. It directly impacts the MHC class I pathway by aiding in the selection and transport of peptides that bind to MHC class I molecules. TAP2 functions alongside related proteins such as TAP1 and tapasin which help facilitate the loading of these peptides onto MHC class I molecules in the endoplasmic reticulum preparing them for cell surface presentation.

Mutations or deficiencies in the TAP2 gene are associated with bare lymphocyte syndrome type 1 (BLS1) a rare immunodeficiency disorder. This syndrome relates to a shortage of antigen presentation on MHC class I molecules leading to increased susceptibility to viral infections. TAP2 along with its partner protein TAP1 is critical in maintaining regular immune surveillance and any disruption in their function can result in profound immunological consequences including impaired cytotoxic T cell responses.
style
left-column

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

style
left-column

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

style
left-column

Product protocols

style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB307282

Anti-TAP2 antibody [EPR26237-82]

BOND RX™ Validated|20ul selling size|RabMAb|Recombinant|KO Validated

Immunohistochemistry - Anti-TAP2 antibody [EPR26237-82] (AB307282)

  • 0
  • 0
Cell Lines & Lysates

AB267195

Human TAP2 knockout A549 cell line

Sanger Sequencing - Human TAP2 knockout A549 cell line (AB267195)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com